Rockefeller Capital Management L.P. Sells 2,588 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Rockefeller Capital Management L.P. cut its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 3.3% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 74,983 shares of the company’s stock after selling 2,588 shares during the quarter. Rockefeller Capital Management L.P.’s holdings in GE HealthCare Technologies were worth $7,037,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in GEHC. LGT Financial Advisors LLC increased its holdings in GE HealthCare Technologies by 1,673.3% in the 3rd quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock worth $25,000 after buying an additional 251 shares in the last quarter. Fred Alger Management LLC bought a new stake in shares of GE HealthCare Technologies in the second quarter worth approximately $26,000. Capital Performance Advisors LLP purchased a new position in shares of GE HealthCare Technologies during the third quarter valued at approximately $26,000. Ashton Thomas Securities LLC bought a new position in GE HealthCare Technologies during the third quarter valued at approximately $26,000. Finally, Elkhorn Partners Limited Partnership purchased a new stake in GE HealthCare Technologies in the second quarter worth approximately $31,000. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other GE HealthCare Technologies news, CEO Roland Rott sold 3,577 shares of the business’s stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total value of $309,338.96. Following the sale, the chief executive officer now owns 24,298 shares in the company, valued at $2,101,291.04. The trade was a 12.83 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.27% of the stock is owned by insiders.

GE HealthCare Technologies Stock Performance

GEHC opened at $82.57 on Wednesday. The company has a 50 day simple moving average of $87.62 and a two-hundred day simple moving average of $83.67. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98. The firm has a market cap of $37.72 billion, a P/E ratio of 22.68, a PEG ratio of 2.97 and a beta of 1.07. GE HealthCare Technologies Inc. has a 1-year low of $67.00 and a 1-year high of $94.55.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Wednesday, October 30th. The company reported $1.14 earnings per share for the quarter, topping the consensus estimate of $1.06 by $0.08. The company had revenue of $4.86 billion during the quarter, compared to the consensus estimate of $4.87 billion. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. GE HealthCare Technologies’s quarterly revenue was up .9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.99 EPS. Equities analysts forecast that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be paid a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.17%. The ex-dividend date is Tuesday, January 14th. This is an increase from GE HealthCare Technologies’s previous quarterly dividend of $0.03. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.30%.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the stock. BTIG Research upgraded shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 target price for the company in a research note on Wednesday, September 18th. Stifel Nicolaus upped their price objective on GE HealthCare Technologies from $100.00 to $102.00 and gave the company a “buy” rating in a research report on Monday, September 30th. JPMorgan Chase & Co. began coverage on GE HealthCare Technologies in a research report on Monday, September 9th. They issued a “neutral” rating and a $90.00 target price on the stock. UBS Group lowered shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and reduced their price target for the company from $84.00 to $74.00 in a research report on Thursday, September 26th. Finally, Wells Fargo & Company raised their price objective on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a report on Thursday, October 31st. One equities research analyst has rated the stock with a sell rating, four have given a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $95.46.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.